Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

Molecular Partners Ag (MOLN) Other Operating Expenses (2021 - 2025)

Historic Other Operating Expenses for Molecular Partners Ag (MOLN) over the last 3 years, with Q3 2025 value amounting to $1.25.

  • Molecular Partners Ag's Other Operating Expenses changed N/A to $1.25 in Q3 2025 from the same period last year, while for Sep 2025 it was $40.2 million, marking a year-over-year increase of 9385037.46%. This contributed to the annual value of $40.0 million for FY2024, which is 9345449.57% up from last year.
  • Latest data reveals that Molecular Partners Ag reported Other Operating Expenses of $1.25 as of Q3 2025.
  • In the past 5 years, Molecular Partners Ag's Other Operating Expenses registered a high of $40.2 million during Q4 2024, and its lowest value of -$42839.5 during Q4 2023.
  • Moreover, its 3-year median value for Other Operating Expenses was $0.63 (2024), whereas its average is $10.0 million.
  • Data for Molecular Partners Ag's Other Operating Expenses shows a peak YoY increase of 9385037.17% (in 2024) and a maximum YoY decrease of 9385037.17% (in 2024) over the last 5 years.
  • Molecular Partners Ag's Other Operating Expenses (Quarter) stood at -$42839.5 in 2023, then skyrocketed by 93850.37% to $40.2 million in 2024, then crashed by 100.0% to $1.25 in 2025.
  • Its Other Operating Expenses stands at $1.25 for Q3 2025, versus $40.2 million for Q4 2024 and -$0.0 for Q2 2024.